GlassScriptPhysician profile
Cheukyin Pang
NPI 1487194163
$3,076.07
in general payments reported to CMS, 2019-2025
11 companies · $1,375 in 2025
The $1,375 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.74 · 2022: $444 · 2023: $271 · 2024: $914 · 2025: $1,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,507 · Food and Beverage: $1,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,507.00 |
| Food and Beverage | $1,053.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $914.31 | 2024 | |
| Getinge USA Sales, LLC | $816.89 | 2025 | Vasoview Hemopro 2 |
| Abbvie INC. | $449.55 | 2025 | |
| Silk Road Medical, INC. | $260.52 | 2022 | |
| Cook Medical LLC | $158.83 | 2022 | |
| Ethicon US, LLC | $135.87 | 2023 | Prolene |
| Maquet Cardiovascular L.L.C. | $109.00 | 2025 | Vasoview Hemopro 2 |
| Intuitive Surgical, INC. | $95.81 | 2023 | Da Vinci Surgical System |
| Cook Incorporated | $58.41 | 2021 | |
| Atricure, INC. | $39.15 | 2023 | |
| Boston Scientific Corporation | $37.73 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheukyin Pang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.